Septic thrombosis of the basilic, axillary, and subclavian veins caused by a peripherally inserted central venous catheter

American Journal of Medicine

Volumn 105, Issue 5, 1998, Pages 446-450

  Andes, David R ^a   Urban, Andrew W ^a   Acher, Charles W ^a   Maki, Dennis G ^a,b  

^a University of Wisconsin Health   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; AXILLARY VEIN; CASE REPORT; CENTRAL VENOUS CATHETER; DEVICE; HUMAN; INTERNAL JUGULAR VEIN; MALE; PRIORITY JOURNAL; SEPSIS; SUBCLAVIAN VEIN; THROMBOSIS; VASCULAR ACCESS; VEIN CATHETERIZATION;

EID: 0032213523     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(98)00287-3     Document Type: Article

References (42)

1. 1. Warden GD, Wilmore DW, Pruitt BA. Central venous thrombosis: a hazard of medical progress. J Trauma. 1973;13:620-626.
2. 2. Popp MB, Law EF, MacMillan. Parenteral nutrition in the burned child: a study of twenty-six patients. Ann Surg. 1974;179:219-225.
3. 3. Strinden WD, Helgersen RB, Maki DG. Candida septic thrombosis of the great central veins associated with central catheters: clinical features and management. Ann Surg. 1985:202:653-657.
4. 4. Verghese A, Widrich WC, Arbeit RD. Central venous septic thrombophlebitis: the role of medical therapy. Medicine. 1985;64: 394-400.
5. 5. Pruitt BA, McManus WF, Kim SH, Treat RC. Diagnosis and treatment of cannula- related intravenous sepsis in burn patients. Ann Surg. 1980;191:546-554.
6. 6. Kaufman J, Demas C, Stark K, Flancbaum L. Catheter-related septic central venous thrombosis - current therapeutic options. West J Med. 1986;145:200-203.
7. 7. Ryder MA. Peripherally inserted central venous catheters. Nurs Clin North Am. 1993;28:937-971.
8. 8. Graham DR, Keldermans MM, Klemm LW, et al. Infectious complications among patients receiving home intravenous therapy with peripheral, central, or peripherally placed central venous catheters. Am J Med. 1991;91(suppl 3B):95-100.
9. 9. Loughran SC, Borzatta M. Peripherally inserted central catheters: a report of 2506 catheters days. J PEN. 1994;19:133-136.
10. 10. Lam S, Scannell R, Roessler D, Smith MA. Peripherally inserted central catheters in an acute-care hospital. Arch Intern Med. 1994; 154:1833-1837.
11. 11. Ng PK, Ault MJ, Ellrodt AG, Maldonado L. Peripherally inserted central catheters in general medicine. Mayo Clin Proc. 1997;72:225-233.
12. 12. Maki DG. Yes, Virginia, aseptic technique is very important. Maximal barrier precautions during insertion reduces the risk of central venous catheter-related bacteremia. Infect Cont Hosp Epidemiol. 1994;15:227-230.
13. 13. Pithie A, Soutar JS, Pennington CR. Catheter tip position in central vein thrombosis. J Parenter Enteral Nutr. 1988;12:613-614.
14. 14. Maki DG. Infections caused by intravascular devices used for infusion therapy: pathogenesis, prevention, and management. In: Bisno AL, Waldvogel FA, eds. Infections Associated with Indwelling Medical Devices. 2nd ed. Washington, DC: American Society for Microbiology; 1994:155-211.
15. 15. Stein JM, Pruitt BA. Suppurative thrombophlebitis: a lethal iatrogenic disease. NEJM. 1970;282:1452-1458.
16. 16. Munster AM. Septic thrombophlebitis: a surgical disorder. JAMA. 1974;230:1010-1011.
17. 17. Johnson RA, Zajac RA, Evans ME. Suppurative thrombophlebitis: correlation between pathogen and underlying disease. Infect Control. 1986;7:582-585.
18. 18. Watanakunakorn C, Baird IM. Staphylococcus aureus bacteremia and endocarditis associated with a removeable infected intravenous device. Am J Med. 1977;63:253-255.
19. 19. Albertyn LE, Alcock MK. Diagnosis of internal jugular vein thrombosis. Radiology. 1987;162:505-508.
20. 20. Falk RL, Smith DF. Thrombosis of upper extremity thoracic inlet veins: diagnosis with duplex doppler sonography. Am J Roentgen. 1993;160:957-962.
21. 21. Mori J, Fukua T, Isomoto I, et al. CT diagnosis of catheter-induced septic thrombus of vena cava. J Comput Assist Tomogr. 1990;14: 236-238.
22. 22. Braun IF, Haffman JC, Malko JA, et al. Jugular venous thrombosis: MR imaging. Radiology. 1985;157:357-360.
23. 23. Jarrett F, Maki DG, Chan CK. Management of septic thrombosis of the inferior vena cava caused by candida. Arch Surg. 1978;13:637-639.
24. 24. MacDonald AS, Master SK, Moffitt EA. A comparative study of peripherally inserted silicone catheters for parenteral nutrition. Can Anaesth Soc J. 1977;24:263-269.
25. 25. Giuffrida DF, Bryan-Brown CW, Lumb PD, et al. Central vs peripheral venous catheters in critically ill patients. Chest. 1986;90:806-809.
26. 26. Merrell SW, Peatross BG, Grossman MD, et al. Peripherally inserted central venous catheters: low-risk alternatives for ongoing venous access. West J Med. 1994;160:25-30.
27. 27. Vic-Dupont JM, et al. Ligation of veins in suppurative thrombophlebitis secondary to venous catheterization. Chirurg. 1973;99: 285.
28. 28. Baker CC, et al. Septic phlebitis: a neglected disease. Am J Surg. 1979;138:97-103.
29. 29. La Quaglia MP, Caldwell C, Lucas A, et al. A prospective randomized double-blind trial of bolus urokinase in the treatment of established Hickman catheter sepsis in children. J Ped Surg. 1994;29:742-745.
30. 30. Rose HD. Venous catheter-associated candidemia. Am J Med Sci. 1978;275:265-269.
31. 31. Terpenning MA, Buggy BP, Kauffman CA. Hospital-acquired infective endocarditis. Arch Intern Med. 1988;148:1601-1603.
32. 32. Henderson DK, Edwards JE, Montgomerie JZ. Hematogenous Candida endophthalmitis in patients receiving parenteral hyperalimentation fluids. J Infect Dis. 1981;143:655-661.
33. 33. Jernigan JA, Farr BM. Short-course therapy of catheter-related Staphylococcus aureus bacteremia: a meta-analysis. Ann Intern Med. 1993;119:304-311.
34. 34. Raad II, Sabbagh MF. Optimal duration of therapy for catheter-related Staphylococcus aureus bacteremia: a study of 55 cases and review. Clin Infect Dis. 1992;14:75-82.
35. 35. Bowler I, Conlon C, Crook D, Peto KT. Optimum duration of therapy for catheter related Staphylococcus aureus bacteremia: a cohort study of 75 patients. Abstract 833. Program abstracts of the 32nd Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington, DC: American Society for Microbiology; 1992.
36. 36. Ehni WF, Reller LB. Short-course therapy for catheter-associated Staphylococcus aureus bacteremia. Arch Intern Med. 1989;149:533-536.
37. 37. Mylotte JM, McDermott C. Staphylococcus aureus bacteremia caused by infected intravenous catheters. Am J Infect Control. 1987; 15:1-6.
38. 38. Iannini PB, Crossley K. Therapy of Staphylococcus aureus bacteremia associated with a removable focus of infection. Ann Intern Med. 1976;84:558-560.
39. 39. Erbel R, Rohmann S, Drexler M, et al. Improved diagnostic value of echocardiography in patients with infective endocarditis by transesophageal approach. A prospective study. Eur Heart J. 1988;9:43-53.
40. 40. Mugge A, Daniel WG, Frank G, Lichtlen PR. Echocardiography in infective endocarditis: reassessment of prognostic implications of vegetation size determined by the transthoracic and the transesophageal approach. Am Coll Cardiol. 1989;14:631-638.
41. 41. Pearson ML, and the Hospital Infection Control Practices Advisory Committee. Guideline for prevention of intravscular-device-related infections. Infect Control Hosp Epidemiol. 1996;17:438-473.
42. 42. Raad II, Hohn DC, Gilbreath BJ, et al. Prevention of central venous catheter-related infections by using maximal sterile barrier precautions during insertion. Infect Control Hosp Epidemiol. 1994;15:231-238.